Acropectoral syndrome
Acropectoral Syndrome

Acropectoral syndrome is a rare genetic disorder characterized by the combination of limb and chest wall abnormalities. It is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.
Clinical Features
Individuals with acropectoral syndrome typically present with a range of physical anomalies. These may include:
- Limb Abnormalities: Affected individuals often have malformations of the hands and feet, such as syndactyly (fusion of fingers or toes), polydactyly (extra fingers or toes), or brachydactyly (short fingers or toes).
- Chest Wall Abnormalities: The syndrome is also associated with defects in the chest wall, such as pectus excavatum (sunken chest) or pectus carinatum (protruding chest).
Genetic Basis
Acropectoral syndrome is caused by mutations in specific genes that are involved in the development of the limbs and chest wall. The exact genetic mutations can vary among affected individuals, but they all follow an autosomal dominant inheritance pattern. This means that if one parent has the syndrome, there is a 50% chance of passing the condition to their offspring.
Diagnosis
Diagnosis of acropectoral syndrome is primarily based on clinical evaluation and the identification of characteristic physical features. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes.
Management
Management of acropectoral syndrome is typically supportive and symptomatic. Treatment may involve:
- Surgical Interventions: Corrective surgery may be necessary to address significant limb or chest wall deformities.
- Physical Therapy: To improve mobility and function of the affected limbs.
- Genetic Counseling: For affected individuals and their families to understand the inheritance pattern and risks for future offspring.
Related Pages
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian